CBLL
CeriBell, Inc.
$18.77
+0.03
(+0.16%)
Mkt Cap
712.18M
Volume
196,745
52W Range
10.85-24.33
Sector
Healthcare
Beta
0.99
EPS (TTM)
-1.63
P/E Ratio
-15.00
Revenue (TTM)
95.07M
Rev Growth (5Y)
+50.9%
EPS Growth (5Y)
N/A
Company Description
CeriBell, Inc. develops AI based point-of-care electroencephalography (EEG) technology for the detection and treatment of neurological conditions. The company develops Ceribell System, a novel, point-of-care EEG platform to address the unmet needs of patients in the acute care setting. It also offers EEG disposable headbands; and pocket-sized battery-operated recorders. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. The company was incorporated in 2014 and is based in Sunnyvale, California.
Track Record
Showing latest 4 periods • Swipe for more
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | 89.06M | 65.44M | 45.23M | 25.92M |
| Net Income | (53.41M) | (40.45M) | (29.46M) | (37.16M) |
| EPS | -1.46 | -3.39 | -1.26 | -1.59 |
| Free Cash Flow | (41.58M) | (36.38M) | (30.14M) | (32.52M) |
| FCF / Share | -1.14 | -3.04 | -1.29 | -1.39 |
| Operating CF | (40.81M) | (35.04M) | (29.16M) | (32.00M) |
| Total Assets | 195.80M | 225.41M | 58.92M | 86.46M |
| Total Debt | 22.28M | 21.96M | 14.20M | 18.22M |
| Cash & Equiv | 40.48M | 194.37M | 34.49M | 68.23M |
| Book Value | 155.34M | 191.16M | (112.25M) | (86.40M) |
| Return on Equity | -0.34 | -0.21 | N/A | N/A |
| Metric | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 26.49M | 24.78M | 22.59M | 21.20M | 20.49M | 18.53M | 17.20M | 14.86M | 14.86M | 13.13M | 11.61M | 10.24M |
| Net Income | (19.74M) | (13.53M) | (13.46M) | (13.64M) | (12.78M) | (12.58M) | (10.42M) | (8.73M) | (8.73M) | (8.27M) | (7.05M) | (7.07M) |
| EPS | -0.52 | -0.36 | -0.37 | -0.38 | -0.36 | -0.40 | -0.31 | -1.59 | -1.59 | 1.74 | -0.30 | -1.35 |
| Free Cash Flow | (19.42M) | (10.95M) | (11.62M) | (7.60M) | (11.68M) | (10.33M) | (9.11M) | (7.26M) | (9.68M) | (7.36M) | (7.58M) | (8.22M) |
| FCF / Share | -0.52 | -0.29 | -0.32 | -0.21 | -0.33 | -0.33 | -0.27 | -1.32 | -1.76 | -0.32 | -0.33 | -1.57 |
| Operating CF | (19.30M) | (10.77M) | (11.25M) | (7.53M) | (11.40M) | (9.97M) | (8.54M) | (6.98M) | (9.55M) | (6.67M) | (7.43M) | (7.53M) |
| Total Assets | 178.08M | 195.80M | 199.53M | 207.69M | 213.47M | 225.41M | 47.06M | 53.18M | 0 | 58.92M | N/A | N/A |
| Total Debt | 22.12M | 22.28M | 21.34M | 21.55M | 21.76M | 21.96M | 22.12M | 22.22M | 0 | 14.20M | N/A | N/A |
| Cash & Equiv | 45.25M | 40.48M | 23.74M | 40.14M | 153.36M | 194.37M | 14.11M | 24.36M | 0 | 34.49M | N/A | N/A |
| Book Value | 140.81M | 155.34M | 164.08M | 172.16M | 180.88M | 191.16M | (135.98M) | (127.28M) | 35.16M | (112.25M) | N/A | N/A |
| Return on Equity | -0.14 | -0.09 | -0.08 | -0.08 | -0.07 | -0.07 | N/A | N/A | -0.25 | N/A | N/A | N/A |
CBLL News
Ceribell to Participate in the William Blair 46th Annual Growth Stock Conference
CeriBell Sees ‘Early Innings' Growth as Hospital Accounts and Usage Hit Records
CeriBell, Inc. (CBLL) Presents at Bank of America Global Healthcare Conference 2026 Transcript
CeriBell, Inc. (CBLL) Q1 2026 Earnings Call Transcript
CeriBell Q1 Earnings Call Highlights
CeriBell, Inc. (CBLL) Reports Q1 Loss, Beats Revenue Estimates
Ceribell Reports First Quarter 2026 Financial Results
Ceribell to Participate in the Bank of America Securities 2026 Health Care Conference
Ceribell to Report First Quarter 2026 Financial Results on May 11, 2026
CeriBell Highlights 2026 Growth Plan at TD Cowen: 25%-29% Guide, VA Ramp, Delirium Pilot